FDA updates providers on lymphoma risk associated with breast implants

The Food and Drug Administration yesterday updated health care providers about a type of lymphoma associated with breast implants and recommendations to inform patients about the risk and report, evaluate and treat the condition. Providers, patients and manufacturers have reported 457 cases of breast implant-associated anaplastic large cell lymphoma since 2010, including nine deaths. For more information, visit www.fda.gov.